Re:GlaxoSmithKline makes $300M investment in 23andMe, forms ...
by mikec3010 on Wednesday July 25, 2018 @03:10PM
(#17611937)
Another way they could abuse this would be to find some loosely genetic-based "treatment" that just so happens to require expensive DNA tests. I'm sure it's more profitable to use the universal fear of cancer to sell tests than it is to actually attack cancerous cells directly.
[ Parent
| on HN ]
There are no comments on this comment yet.